GGrantIndex
Sort

50,496 grants matching lung cancer

Reprogramming the pancreatic tumor microenvironment with immunotherapy

$429,841
Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA

ApoVax104-TB as a Novel Vaccine for Tuberculosis

$429,811
Kathryn J. Macleod · Apovax, Inc. · R43 · FY2009 · AI

Histone Deacetylation Signaling in Aging and Cancer Pathways

$429,811
Katrin F Chua · Palo Alto Veterans Instit For Research · R01 · FY2024 · CA

Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia

$429,791
Yi-Ping Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA

Combined Cancer Therapy with RF Ablation and Drug-Loaded Nanopreparations

$429,790
S. Nahum Goldberg · Northeastern University · U54 · FY2011 · CA

Sorting of Plasma Membrane Proteins in Epithelial Cells

$429,788
Enrique J Rodriguez-Boulan · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · GM

SPORE IN LUNG CANCER

$429,778
University Of Colorado Denver · P50 · FY2001 · CA

Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials

$429,776
William Lake · Information Management Services, Inc. · N02 · FY2011 · CA

Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes

$429,763
Sumitra Deb · Virginia Commonwealth University · R01 · FY2020 · CA

Genetics of Tobacco and Alcohol Related Cancers

$429,672
International Agency For Res On Cancer · R01 · FY2005 · CA

Neuronally Active Proteins in IPF

$429,656
Erica L Herzog · Yale University · R01 · FY2016 · HL

Project 2: Combined CAR-T cell therapy

$429,640
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA

NICHD Maternal Fetal Medicine Units Network

$429,632
Jorge Enrique Tolosa · Oregon Health & Science University · U10 · FY2008 · HD

Enhancing neutrophil function in neutropenia-related pneumonia

$429,583
Hongbo R Luo · Boston Children'S Hospital · R01 · FY2010 · HL

Identification of TBK1 inhibitors in KRAS-dependent lung cancer

$429,576
William C Hahn · Dana-Farber Cancer Inst · P01 · FY2012 · CA

Identification and Study of Novel EGFR Kinase Inhibtors

$429,576
Pasi A Janne · Dana-Farber Cancer Inst · P01 · FY2012 · CA

Identifying Genes that Cause Lung Cancer to Progress

$429,572
California Pacific Med Ctr Res Institute · R01 · FY2005 · CA

NIMHD Adjunct Investigator Program

$429,520
Kelvin Choi · National Institute On Minority Health And Health Disparities · ZIJ · FY2024 · MD

Extracellular Sulfatases As Novel Biomarkers For Early Detection of Cancer

$429,514
Hassan Lemjabbar-Alaoui · University Of California, San Francisco · U01 · FY2016 · CA

Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340

$429,509
Carolyn Calfee · University Of California, San Francisco · P50 · FY2016 · CA

Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug

$429,426
Weidong Wang · National Institute On Aging · ZIA · FY2023 · AG

Recalibrating the Lung Cancer Policy Model to Address Lung Cancer Risk and Lung Cancer Screening Practices in Real-World Populations

$429,399
Chi-Fu Yang · Massachusetts General Hospital · R21 · FY2025 · CA

Impacting Cell Growth through altered circadian proteolysis

$429,351
Katja A Lamia · Scripps Research Institute, The · R01 · FY2019 · CA

Unlocking mechanisms of resistance to targeted therapy in thyroid cancer

$429,350
Myriem Boufraqech · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$429,318
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA